SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Hansson Karl Johan) "

Sökning: WFRF:(Hansson Karl Johan)

  • Resultat 1-10 av 16
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Hansson, Jonas, et al. (författare)
  • Biomarkers of Extracellular Matrix Metabolism (MMP-9 and TIMP-1) and Risk of Stroke, Myocardial Infarction, and Cause-Specific Mortality Cohort Study
  • 2011
  • Ingår i: PLoS ONE. - 1932-6203. ; 6:1, s. e16185
  • Tidskriftsartikel (refereegranskat)abstract
    • Objective: Turnover of the extracellular matrix in all solid organs is governed mainly by a balance between the degrading matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs). An altered extracellular matrix metabolism has been implicated in a variety of diseases. We investigated relations of serum levels of MMP-9 and TIMP-1 to mortality risk from an etiological perspective.Design: The prospective Uppsala Longitudinal Study of Adult Men (ULSAM) cohort, followed from 1991-1995 for up to 18.1 years. A random population-based sample of 1,082 71-year-old men, no loss to follow-up. Endpoints were all-cause (n = 628), cardiovascular (n = 230), non-cardiovascular (n = 398) and cancer mortality (n = 178), and fatal or non-fatal myocardial infarction (n = 138) or stroke (n = 163).Results: Serum MMP-9 and TIMP-1 levels were associated with risk of all-cause mortality (Cox proportional hazard ratio [HR] per standard deviation 1.10, 95% confidence interval [CI] 1.03-1.19; and 1.11, 1.02-1.20; respectively). TIMP-1 levels were mainly related to risks of cardiovascular mortality and stroke (HR per standard deviation 1.22, 95% CI 1.09-1.37; and 1.18, 1.04-1.35; respectively). All relations except those of TIMP-1 to stroke risk were attenuated by adjustment for cardiovascular disease risk factors. Relations in a subsample without cardiovascular disease or cancer were similar to those in the total sample.Conclusion: In this community-based cohort of elderly men, serum MMP-9 and TIMP-1 levels were related to mortality risk. An altered extracellular matrix metabolism may be involved in several detrimental pathways, and circulating MMP-9 or TIMP-1 levels may be relevant markers thereof.
2.
3.
  • Rönnelid, Johan, et al. (författare)
  • Anticitrullinated protein/peptide antibody multiplexing defines an extended group of ACPA-positive rheumatoid arthritis patients with distinct genetic and environmental determinants.
  • 2018
  • Ingår i: Annals of the Rheumatic Diseases. - 0003-4967 .- 1468-2060. ; 77:2, s. 203-211
  • Tidskriftsartikel (refereegranskat)abstract
    • INTRODUCTION: The second generation anticycliccitrullinated peptide (anti-CCP2) assay detects the majority but not all anticitrullinated protein/peptide antibodies (ACPA). Anti-CCP2-positive rheumatoid arthritis (RA) is associated with HLA-DRB1* shared epitope (SE) alleles and smoking. Using a multiplex assay to detect multiple specific ACPA, we have investigated the fine specificity of individual ACPA responses and the biological impact of additional ACPA reactivity among anti-CCP2-negative patients.METHODS: We investigated 2825 patients with RA and 551 healthy controls with full data on anti-CCP2, HLA-DRB1* alleles and smoking history concerning reactivity against 16 citrullinated peptides and arginine control peptides with a multiplex array.RESULTS: The prevalence of the 16 ACPA specificities ranged from 9% to 58%. When reactivity to arginine peptides was subtracted, the mean diagnostic sensitivity increased by 3.2% with maintained 98% specificity. Of the anti-CCP2-negative patients, 16% were found to be ACPA positive. All ACPA specificities associated with SE, and all but one with smoking. Correction for arginine reactivity also conveyed a stronger association with SE for 13/16 peptides. Importantly, when all ACPA specificities were analysed together, SE and smoking associated with RA in synergy among ACPA positive, but not among ACPA-negative subjects also in the anti-CCP2-negative subset.CONCLUSIONS: Multiplexing detects an enlarged group of ACPA-positive but anti-CCP2-negative patients with genetic and environmental attributes previously assigned to anti-CCP2-positive patients. The individual correction for arginine peptide reactivity confers both higher diagnostic sensitivity and stronger association to SE than gross ACPA measurement.
  •  
4.
  • Skillbäck, Tobias, et al. (författare)
  • A novel quantification-driven proteomic strategy identifies an endogenous peptide of pleiotrophin as a new biomarker of Alzheimer's disease
  • 2017
  • Ingår i: Scientific Reports. - 2045-2322. ; 7
  • Tidskriftsartikel (refereegranskat)abstract
    • We present a new, quantification-driven proteomic approach to identifying biomarkers. In contrast to the identification-driven approach, limited in scope to peptides that are identified by database searching in the first step, all MS data are considered to select biomarker candidates. The endopeptidome of cerebrospinal fluid from 40 Alzheimer's disease (AD) patients, 40 subjects with mild cognitive impairment, and 40 controls with subjective cognitive decline was analyzed using multiplex isobaric labeling. Spectral clustering was used to match MS/MS spectra. The top biomarker candidate cluster (215% higher in AD compared to controls, area under ROC curve = 0.96) was identified as a fragment of pleiotrophin located near the protein's C-terminus. Analysis of another cohort (n = 60 over four clinical groups) verified that the biomarker was increased in AD patients while no change in controls, Parkinson's disease or progressive supranuclear palsy was observed. The identification of the novel biomarker pleiotrophin 151-166 demonstrates that our quantification-driven proteomic approach is a promising method for biomarker discovery, which may be universally applicable in clinical proteomics.
5.
  • Alsanius, Beatrix, et al. (författare)
  • Ett steg närmare mars
  • 2006
  • Ingår i: Viola. - 0042-6407. ; 24, s. 44-45
  • Tidskriftsartikel (populärvet., debatt m.m.)
  •  
6.
  •  
7.
  •  
8.
9.
  • Hansson, Karl, 1985-, et al. (författare)
  • Expanding the cerebrospinal fluid endopeptidome
  • 2017
  • Ingår i: Proteomics. - 1615-9853. ; 17:5
  • Tidskriftsartikel (refereegranskat)abstract
    • Biomarkers of neurodegenerative disorders are needed to assist in diagnosis, to monitor disease progression and therapeutic interventions, and to provide insight into disease mechanisms. One route to identify such biomarkers is by proteomic and peptidomic analysis of cerebrospinal fluid (CSF). In the current study, we performed an in-depth analysis of the human CSF endopeptidome to establish an inventory thatmay serve as a basis for future targeted biomarker studies. High-pH RP HPLC was employed for off-line sample prefractionation followed by low-pH nano-LC-MS analysis. Different software programs and scoring algorithms for peptide identification were employed and compared. A total of 18 031 endogenous peptides were identified at a FDR of 1%, increasing the number of known endogenous CSF peptides 10fold compared to previous studies. The peptides were derived from 2 053 proteins of which more than 60 have been linked to neurodegeneration. Notably, among the findings were six peptides derived from microtubule-associated protein tau, three of which span the diagnostically interesting threonine-181 (Tau-F isoform). Also, 213 peptides from amyloid precursor protein were identified, 58 of which were partially or completely within the sequence of amyloid beta 1-40/42, as well as 109 peptides from apolipoprotein E, spanning sequences that discriminate between the E2/E3/E4 isoforms of the protein.
  •  
10.
  • Hansson, Karl, 1985-, et al. (författare)
  • Sample Preparation for Endopeptidomic Analysis in Human Cerebrospinal Fluid
  • 2017
  • Ingår i: Jove-Journal of Visualized Experiments. - 1940-087X. ; :130
  • Tidskriftsartikel (refereegranskat)abstract
    • This protocol describes a method developed to identify endogenous peptides in human cerebrospinal fluid (CSF). For this purpose, a previously developed method based on molecular weight cut-off (MWCO) filtration and mass spectrometric analysis was combined with an offline high-pH reverse phase HPLC pre-fractionation step. Secretion into CSF is the main pathway for removal of molecules shed by cells of the central nervous system. Thus, many processes in the central nervous system are reflected in the CSF, rendering it a valuable diagnostic fluid. CSF has a complex composition, containing proteins that span a concentration range of 8-9 orders of magnitude. Besides proteins, previous studies have also demonstrated the presence of a large number of endogenous peptides. While less extensively studied than proteins, these may also hold potential interest as biomarkers. Endogenous peptides were separated from the CSF protein content through MWCO filtration. By removing a majority of the protein content from the sample, it is possible to increase the sample volume studied and thereby also the total amount of the endogenous peptides. The complexity of the filtrated peptide mixture was addressed by including a reverse phase (RP) HPLC pre-fractionation step at alkaline pH prior to LC-MS analysis. The fractionation was combined with a simple concatenation scheme where 60 fractions were pooled into 12, analysis time consumption could thereby be reduced while still largely avoiding co-elution. Automated peptide identification was performed by using three different peptide/protein identification software programs and subsequently combining the results. The different programs were complementary rather than comparable with less than 15% of the identifications overlapped between the three.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 16
Åtkomst
fritt online (5)
Typ av publikation
tidskriftsartikel (10)
bokkapitel (3)
konferensbidrag (1)
rapport (1)
samlingsverk (redaktörskap) (1)
Typ av innehåll
refereegranskat (9)
övrigt vetenskapligt (6)
populärvet., debatt m.m. (1)
Författare/redaktör
Gobom, Johan, (4)
Blennow, Kaj, 1958-, (3)
Zetterberg, Henrik, ... (3)
Skillbäck, Tobias, (3)
Hansson, Karl-Johan (3)
Hansson, Karl, 1985- ... (3)
visa fler...
Brinkmalm, Gunnar, (2)
Jarl, Johan, (2)
Gerdtham, Ulf, (2)
Holmén Larsson, Jess ... (2)
Straarup, Jørgen, 19 ... (2)
Desatnik, Peter (2)
Pernevik, Elin, (2)
Peetz Hansson, Ulrik ... (2)
Prutz, Karl-Goran, (2)
Lind, Lars, (1)
Sundström, Johan, (1)
Hansson, Jonas, (1)
Blennow, Kaj (1)
Zetterberg, Henrik (1)
Larsson, Anders, (1)
Åström, Karl Johan, (1)
Portelius, Erik, 197 ... (1)
Rönnelid, Johan, (1)
Alfredsson, Lars (1)
Hansson, Monika, (1)
Ärnlöv, Johan, (1)
Arnlov, J. (1)
Ingelsson, Erik, (1)
Hiltunen, Mikko (1)
Hägglund, Hans, (1)
Alsanius, Beatrix, (1)
Mathsson, Linda (1)
Persson, Karl-Johan, (1)
Michaëlsson, Karl, 1 ... (1)
Michaelsson, K (1)
Mirgorodskaya, Ekate ... (1)
Bergstrand, Karl-Joh ... (1)
Sandin, Håkan (1)
Hansson, Torbjörn (1)
Sundstrom, J (1)
Hansson, Anders, (1)
Vasan, Ramachandran ... (1)
Hansson, Oskar (1)
Blomqvist, Lennart (1)
Holmdahl, Rikard, (1)
Hansson, Lotta, (1)
Torkzad, Michael R., (1)
Jakobsson, Per Johan (1)
Klareskog, Lars (1)
visa färre...
Lärosäte
Lunds universitet (6)
Uppsala universitet (4)
Göteborgs universitet (4)
Umeå universitet (2)
Karolinska Institutet (2)
Sveriges Lantbruksuniversitet (1)
visa fler...
Högskolan Dalarna (1)
visa färre...
Språk
Engelska (9)
Svenska (7)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (10)
Humaniora (3)
Teknik (2)
Naturvetenskap (1)
Lantbruksvetenskap (1)

År

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy